Questions for Future Research
Q: Because healthy oligodendrocyte progenitor cells are important for the child’s developing brain, how could further characterization of NG2 isoforms help prevent drugs from damaging those beneficial cells?
Q: Could NG2-binding peptides cross the blood-brain barrier to deliver anti-cancer therapies precisely to tumor sites?
Source: “The Role of NG2 Proteoglycan in Glioma.” S. Yadavilli, E.I. Hwang, R. J. Packer, and J. Nazarian. Published by Translational Oncology on February 2016.
You might also like
LATEST TWEETS FROM INNOVATION DISTRICT
“Necessity is the mother of invention.”
I speak with @ChildrensNatl's Dr. Kolaleh Eskandanian about the pediatric medical device competition that gave $250k in awards.
Cool technology you'll see First On @ABC7News at 4 pm.
Despite well-documented similarities, MIS-C and Kawasaki also have some specific, clear differences. Understanding how the two are different will improve care and treatment for both: http://spr.ly/6019GeASc